Topical Cannabis for Chronic Musculoskeletal Pain

Some inclusion/exclusion criteria are purposely omitted at this time to preserve scientific integrity. They will be included after the trial is complete. Inclusion Criteria: * Chronic peripheral joint pain * Desire and intent to use a topical cannabinoid product containing cannabidiol (CBD) or a combination of CBD and tetrahydrocannabinol (THC) to alleviate this pain Exclusion Criteria: * Current or prior use of topical cannabis * Unwilling or unable to discontinue other (non-topical) cannabis use for four weeks prior to and during study participation through week two * Intent to use a THC-predominant topical product (ratio greater than 1:1 of THC to CBD) * Current or history of substance use disorder * History or diagnosis of schizophrenia, bipolar or a psychotic disorder * Surgery on the affected musculoskeletal location within the 3 months prior to enrollment * Planned surgery or procedure on the affected musculoskeletal location during participation in the study * Allergy or prior severe adverse reaction to cannabis (cardiovascular event, psychosis, etc) * Current or prior cannabis abuse/dependence * Cognitive disability that interferes with ability to provide consent or understand study procedures * History of seizure disorder * Pending legal action or workers compensation * Pregnant females or females intending to become pregnant during the study period * Lactating females * Chronic/severe medical illness (renal disease, liver disease, cancer, significant cardiovascular disease, or history of myocardial infarction) * Active component military